Adoptive transfer of gene-modified T-cells engineered to express high-affinity tcr's for cancer-testis antigens NY-ESO-1 or lage-1, in multiple myeloma (MM) patients post autologous hematopoietic stem cell transplant (ASCT)

✍ Scribed by Levine, B.L.; Rapoport, A.P.; Stadtmauer, E.A.; Vogl, D.T.; Weiss, B.; Binder-Scholl, G.K.; Smethurst, D.P.; Brewer, J.E.; Bennett, A.D.; Gerry, A.B.; Pumphrey, N.J.; Tayton-Martin, H.K.; Ribiero, L.; Veloso, E.A.; Finklestein, J.; Kulikovskaya, I.; Gupta, M.; Suppa, E.; Mikheeva, T.; Zheng, Z.; Brennan, A.L.; Bersenev, A.; Tripic, T.; Cribioli, E.; Cotte, J.; Badros, A.Z.; Yanovich, S.; Akpek, G.; McConville, H.; Kerr, N.; Philip, S.; Betts, K.; Westphal, S.; Kalos, M.; Jacobsen, B.K.; June, C.H.

• Book ID: 122389377
• Publisher: Informa plc
• Year: 2013
• Tongue: English
• Weight: 80 KB
• Volume: 15
• Category: Article
• ISSN: 1465-3249
• DOI: 10.1016/j.jcyt.2013.01.046